Evidence map›Paper›PMID 40312377›Full record

ArticleImplementation science : IS2025

For girls and women (4GW) HPV RCT protocol: a crowdsourced, pragmatic stepped-wedge cluster randomized trial to improve uptake of HPV vaccination and screening among mother-daughter dyads in Nigeria.

Juliet Iwelunmor, Agatha E Wapmuk, Ekenechukwu Kokelu, Temitope Ojo, Olufunto Olusanya, Titilola Gbaja-Biamila, Folahanmi T Akinsolu, Adesola Z Musa, Hong Xian, Olunike R Abodunrin and 18 more

Registry-linked trialAbstract readClinical Trial Protocol
In one paragraph

Article in Implementation science : IS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06728085 (A Pragmatic Trial on Actions For Collaborative Community Engaged Strategies for HPV), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06728085 naactive not recruitingnot on this map

A Pragmatic Trial on Actions For Collaborative Community Engaged Strategies for HPV

TypeinterventionalSponsorWashington University School of MedicineRan2025 to 2027Enrolled1,838ConditionsHPVArmsBaseline Assessment For Mother-Daughter Day HPV Campaign, Implement Mother-Daugther Day HPV Campaign, Post-Implementation Follow-Up
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Juliet IwelunmorDivision of Infectious Diseases, Washington University School of Medicine in St. Louis, 4523 Clayton Ave., MSC 8051 - 0043 - 15, St. Louis , MO, 63110, USA. ijuliet@wustl.edu.
Agatha E WapmukClinical Sciences Department, Nigerian Institute of Medical Research, Lagos, Nigeria.
Ekenechukwu KokeluDivision of Infectious Diseases, Washington University School of Medicine in St. Louis, 4523 Clayton Ave., MSC 8051 - 0043 - 15, St. Louis , MO, 63110, USA.
Temitope OjoDivision of Infectious Diseases, Washington University School of Medicine in St. Louis, 4523 Clayton Ave., MSC 8051 - 0043 - 15, St. Louis , MO, 63110, USA.
Olufunto OlusanyaDivision of Infectious Diseases, Washington University School of Medicine in St. Louis, 4523 Clayton Ave., MSC 8051 - 0043 - 15, St. Louis , MO, 63110, USA.
Titilola Gbaja-BiamilaDivision of Infectious Diseases, Washington University School of Medicine in St. Louis, 4523 Clayton Ave., MSC 8051 - 0043 - 15, St. Louis , MO, 63110, USA.
Folahanmi T AkinsoluClinical Sciences Department, Nigerian Institute of Medical Research, Lagos, Nigeria.
Adesola Z MusaClinical Sciences Department, Nigerian Institute of Medical Research, Lagos, Nigeria.
Hong XianCollege for Public Health & Social Justice, Saint Louis University, Saint Louis, MO, USA.
Olunike R AbodunrinCenter for Reproduction and Population Health Studies, Nigerian Institute of Medical Research, Lagos, Nigeria.
Peter KaluluDivision of Infectious Diseases, Washington University School of Medicine in St. Louis, 4523 Clayton Ave., MSC 8051 - 0043 - 15, St. Louis , MO, 63110, USA.
Angel ObiorahDivision of Infectious Diseases, Washington University School of Medicine in St. Louis, 4523 Clayton Ave., MSC 8051 - 0043 - 15, St. Louis , MO, 63110, USA.
Maria AfadapaDivision of Infectious Diseases, Washington University School of Medicine in St. Louis, 4523 Clayton Ave., MSC 8051 - 0043 - 15, St. Louis , MO, 63110, USA.
Nkiruka ObodoechinaDivision of Infectious Diseases, Washington University School of Medicine in St. Louis, 4523 Clayton Ave., MSC 8051 - 0043 - 15, St. Louis , MO, 63110, USA.
Ucheoma NwaozuruDepartment of Implementation Science, Division of Public Health Sciences, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Onyeka AnikamaduDivision of Infectious Diseases, Washington University School of Medicine in St. Louis, 4523 Clayton Ave., MSC 8051 - 0043 - 15, St. Louis , MO, 63110, USA.
Jennifer SmithInstitute of Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Benedict N AzuoguDepartment of Anaesthesia, Ebonyi State University, Abakaliki, Ebonyi State, Nigeria.
Kayode AjenifujaDepartment of Obstetrics and Gynaecology, Obafemi Awolowo University, Osun State, Ile-Ife, Nigeria.
Mengmeng JiaNational Institute of Pathogen Biology, Chinese Academy of Medical Sciences, Beijing, 102629, China.
Assanatou BamogoDepartment of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Abdulhammed BabatundeDepartment of Medicine and Surgery, Faculty of Clinical Sciences, College of Medicine, University of Ibadan, Oyo, Nigeria.
Jason J OngImplementation Science Department, Feinburg School of Medicine, Northwestern University, Chicago, USA.
Lei ZhangMelbourne Sexual Health Centre, Alfred Health, Melbourne, Australia.
Zhuoru ZouSchool of Public Health, Xi'an Jiaotong University XJTU · Health Science Centre, Xi'an, Shaanxi, China.
Collins O AirhihenbuwaHealth Policy and Behavioral Sciences, School of Public Health, Georgia State University, Atlanta, GA, USA.
Joseph D TuckerDepartment of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Oliver C EzechiClinical Sciences Department, Nigerian Institute of Medical Research, Lagos, Nigeria.

Funding

Actions for Collaborative Community Engaged Strategies for HPV (ACCESS-HPV)R01CA271033 · NCI · WASHINGTON UNIVERSITY · PI OLIVER CHUKWUJEKWU EZECHI, Juliet Iwelunmor · 2022 to 2026
$2.5M
NCI NIH HHS R01 CA271033NCI NIH HHS R01CA271033
6 · The paper itself

Abstract

backgroundExpanding human papillomavirus (HPV) vaccination for girls and HPV self-collection for women can reduce the global burden of cervical cancer. However, HPV vaccination and self-collection services are rarely implemented simultaneously in mother-daughter dyads, leaving a critical gap in cervical cancer prevention. From 2023 to 2024, a community-engaged model for combined HPV vaccination and screening was co-designed using crowdsourcing open calls and designathons with mother-daughter teams and pilot-tested by trained research facilitators. This study explores the impact of this crowdsourced, community-engaged mother-daughter campaign and implementation strategy bundle on HPV vaccination among girls and HPV screening among their mothers in Nigeria over 6 months in 18 Nigerian local government areas (LGAs).

methodsA hybrid effectiveness-implementation type II pragmatic stepped-wedge cluster randomized control trial has been employed to the effectiveness of an implementation strategy bundle; a crowdsourced, tailored, community-engaged, mother-daughter HPV campaign on increasing uptake of HPV vaccination among girls aged 9-14 and HPV screening uptake among women aged 30-49 in Nigeria. The mother-daughter campaign will be tailored to local sites and conducted among 612 mother-daughter dyads (1,224 participants) recruited from 18 LGAs in six geopolitical zones of Nigeria. Trained community health workers will collect baseline data and implement a mother-daughter campaign that will provide education on cervical cancer control and access to onsite services for HPV vaccination and screening in a private area while engaging mothers and daughters simultaneously to increase uptake of the services. A mixed-methods evaluative and iterative assessment will be conducted using Proctor's Implementation Outcomes Framework and the PEN- 3 cultural model. The primary outcomes are the uptake of HPV preventive measures-HPV vaccination (one dose) among girls (ascertained by onsite clinical records of vaccine uptake) and HPV self-collection completion among mothers (ascertained by laboratory receipt of self-collected specimens) within six months of trial enrollment. Pre-post effectiveness and cost of study components are embedded in the implementation and sustainment phases, compared to pre-implementation data assessed for each LGA. DISCUSSION: This study is a unique dyadic intervention focused on both girls and their mothers or female caregivers to drive cervical cancer control in Africa. Findings have the potential to inform local and global policies aimed at reducing the cervical cancer burden in African countries like Nigeria, eliminating missed opportunities by closing the research-to-translation gap. The protocol was registered with clinicaltrials.gov under registration NCT06728085.

Indexed as

MothersPapillomavirus InfectionsPapillomavirus VaccinesPatient Acceptance of Health CareUterine Cervical NeoplasmsAdolescentAdultCrowdsourcingEarly Detection of CancerFemaleHumansMass ScreeningNigeriaPragmatic Clinical Trials as TopicRandomized Controlled Trials as TopicVaccinationPapillomavirus Vaccines

Identifiers

PMID40312377
PMCPMC12046803

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.